The subject of the invention is the method of chemical tagging, reading the chemical marker, and reading the authentication of the code generated using changes in the concentration of the tagging substances in the tablet coating.
Counterfeit medicine is a severe problem in the pharmaceutical industry. Both brand and generic medicines, as well as prescription and non-prescription medications, are the subject of counterfeiting. An average consumer is unable to differentiate the authentic and counterfeit medicine—both the packaging and the medicine form seem to be correct, while the difference lies in the form or dose of the active substance, and the presence of harmful substances. According to the Pharmaceutical Security Institute, over half a thousand counterfeit versions of pharmaceuticals, ranging from painkillers to antibiotics and anticancer drugs, are present on the global market. This problem affects at least 123 countries. Most of the counterfeit medicine is entering the legal drug supply chain are forged live-saving medicines.
According to the World Health Organization, over a million people globally die every year because of counterfeit medicine. 15% drugs on the global market are counterfeit. However, the problem affects mainly some regions of Asia, Africa, and South America where the percentage can reach even 70% in the developing countries.
According to the European Parliament and Council Directive 2011/62/EU from Jun. 8, 2011, a pan-European computer system that will enable the verification of the medicine authenticity based on the unique packaging codes will start operating in 2019. This applies to all prescription drugs and only certain non-prescription medicines. A pharmacist will scan the codes before the drug is released to the patient. Therefore, many companies have been established which offer labelling of the packagings with numerical codes, bar codes, or QR codes that can be scanned using mobile applications or special scanners. Labelling of the packaging does not solve the problem of the counterfeit products. Technologies enabling the direct identification of the drugs are required.
The approach proposed in the present invention offers multilevel protection of the product authenticity based on the conformity of the codes on the packagings with the unique chemical code obtained by the addition of the combination of the compounds in a specific proportion. It is a simple and economically advantageous method that does not require expensive and sophisticated technologies. Tablets authentication is conducted in laboratories ensuring high accuracy and reliability of the results.
The chemical tag consists of at least two compounds to obtain the proportion. In consequence, the tag with the serial code present on the packaging gives a unique identification for the tablets lot. The invention provides the variability of codes for each manufacturing batch.
The compounds which are not present in the drug coating or are present in a constant value can be used for the tagging. Small-molecule compounds with good UV absorption are preferred.
The subject of the present invention is the method of medicine chemical tagging using a coating, comprising of:
The subject of the present invention is the method of the chemical tagging of tablets where the marker is defined as a mutual, absolute, and non-unitary ratio of the labelling substances.
The method in which parabens can be used as the labelling substances.
The method which can be used for any type of the coating.
The method in which the addition of the labelling substance does not change the pharmacokinetic and pharmacodynamic properties of the coated substance.
The method in which the difference of the absolute ratio between normalised concentration value and normalised mass of the added substances cannot exceed 0.02 for the correct reading.
Tab. 1—Coating composition given in the compound mass percentage
Tab. 2—Mass of the parabens used for the experiment given in milligrams
Tab. 3—Concentration of parabens obtained as a result of the chromatographic analyses given in milligrams per millilitre
Tab. 4—Difference between the expected value and the obtained value of the normalised results (absolute, nonunitary value)
The invention is illustrated by the following embodiments, including but not limited to.
(concentration of the selected compound)/(sum of the concentrations of all compounds determined in the sample)
(mass of the selected compound)/(mass of all compounds added to the sample)
(concentration of the selected compound)/(sum of the concentrations of all compounds determined in the sample)
(mass of the selected compound)/(mass of all compounds added to the sample)
The tagging method can be used universally, regardless of the coating composition and the coated active substance. Thanks to the easy analytical method, it is possible to verify the authenticity of the tablet in most of the analytical laboratories.
Number | Date | Country | Kind |
---|---|---|---|
P.427437 | Oct 2018 | PL | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/PL2019/000094 | 10/16/2019 | WO | 00 |